AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
GADOBUTROL
9 registrations across 4 African markets— 9 active
Markets with GADOBUTROL
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| GADOVIST Solution For Injection | 🇰🇪Kenya | Bayer Pharma AG | active | Mar 2031 |
| GADOVIT INJECTION | 🇬🇭Ghana | — | active | Mar 2027 |
| GADOVIT INJECTION | 🇬🇭Ghana | — | active | Mar 2027 |
| GADOVIST 7,5 ml | 🇿🇦South Africa | Bayer (Pty) Ltd û Isando | active | Jan 1900 |
| GADOVIST 30 ml | 🇿🇦South Africa | Bayer (Pty) Ltd û Isando | active | Jan 1900 |
| GADOVIST 10 ml | 🇿🇦South Africa | Bayer (Pty) Ltd û Isando | active | Jan 1900 |
| GADOVIST 15 ml | 🇿🇦South Africa | Bayer (Pty) Ltd û Isando | active | Jan 1900 |
| GADOVIST 65 ml | 🇿🇦South Africa | Bayer (Pty) Ltd û Isando | active | Jan 1900 |
| Gadovist 1.0 mmol/mL Injection Solution for injection | 🇳🇬Nigeria | — | active | — |
GADOBUTROL in Africa — Regulatory Overview
GADOBUTROL is registered across 4 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Ghana, Kenya, Nigeria. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.